Genomma comments on drop in Mexican sales

12 March 2015 - Deborah Wilkes

Archived

Mexico's Genomma Lab has implemented a new commercial strategy in its domestic OTC market, and plans to sell the Marzam distribution company acquired in 2014. The news comes soon after Genomma reported that its Mexican sales had dropped by 43.4% to MXN1.42 billion (US$92 million) in the fourth quarter of 2014.

Click tags below for more information on topics:

Genomma Lab

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: